1. Home
  2. TVRD vs ARBE Comparison

TVRD vs ARBE Comparison

Compare TVRD & ARBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVRD
  • ARBE
  • Stock Information
  • Founded
  • TVRD 2017
  • ARBE 2015
  • Country
  • TVRD United States
  • ARBE Israel
  • Employees
  • TVRD N/A
  • ARBE N/A
  • Industry
  • TVRD Biotechnology: Pharmaceutical Preparations
  • ARBE EDP Services
  • Sector
  • TVRD Health Care
  • ARBE Technology
  • Exchange
  • TVRD Nasdaq
  • ARBE Nasdaq
  • Market Cap
  • TVRD 246.5M
  • ARBE 203.2M
  • IPO Year
  • TVRD N/A
  • ARBE N/A
  • Fundamental
  • Price
  • TVRD $26.91
  • ARBE $1.56
  • Analyst Decision
  • TVRD Strong Buy
  • ARBE Buy
  • Analyst Count
  • TVRD 4
  • ARBE 2
  • Target Price
  • TVRD $58.50
  • ARBE $1.75
  • AVG Volume (30 Days)
  • TVRD 92.7K
  • ARBE 1.5M
  • Earning Date
  • TVRD 08-21-2025
  • ARBE 08-05-2025
  • Dividend Yield
  • TVRD N/A
  • ARBE N/A
  • EPS Growth
  • TVRD N/A
  • ARBE N/A
  • EPS
  • TVRD N/A
  • ARBE N/A
  • Revenue
  • TVRD N/A
  • ARBE $671,000.00
  • Revenue This Year
  • TVRD N/A
  • ARBE $285.16
  • Revenue Next Year
  • TVRD N/A
  • ARBE $370.11
  • P/E Ratio
  • TVRD N/A
  • ARBE N/A
  • Revenue Growth
  • TVRD N/A
  • ARBE N/A
  • 52 Week Low
  • TVRD $8.13
  • ARBE $0.85
  • 52 Week High
  • TVRD $34.31
  • ARBE $5.09
  • Technical
  • Relative Strength Index (RSI)
  • TVRD N/A
  • ARBE 45.68
  • Support Level
  • TVRD N/A
  • ARBE $1.43
  • Resistance Level
  • TVRD N/A
  • ARBE $1.80
  • Average True Range (ATR)
  • TVRD 0.00
  • ARBE 0.12
  • MACD
  • TVRD 0.00
  • ARBE -0.02
  • Stochastic Oscillator
  • TVRD 0.00
  • ARBE 25.10

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

About ARBE Arbe Robotics Ltd.

Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.

Share on Social Networks: